ClinicalTrials.gg
Drug

Florbetaben f-18 clinical trials

Also written Neuraceq and Florbetaben.

studies test it
15
open now
1
in phase 3
2
first study started
2008

How each study uses florbetaben f-18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the florbetaben f-18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
20 Feb 2014 · Neuraceq · EMEA/H/C/002553 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Florbetaben (BAY94-9172)
4
[18F]Florbetaben
3
FBB
3

Brand

Neuraceq
4

Development codes

Bay 91-9172
1

Other names

Florbetaben
3
Florbetaben F18
1

Studies by the year they started

15 studies that test it; most in 2008 (2)

Studies that test florbetaben f-18, by start year
YearStudies
20082
20092
20101
20152
20161
20181
20191
20201
20211
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
1
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 7

Lantheus Biosciences Ltd. (4) · Lantheus Germany GmbH (2) · New York State Psychiatric Institute (1) · Sinotau Pharmaceutical Group (1) · Stanford University (1) · Ulsan University Hospital (1) · Molecular NeuroImaging (1) · Life Molecular Imaging SA (1)

Often tested with

Tested in the same studies.

NOS F-18 (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses florbetaben f-18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Given beside what is tested · 1 — florbetaben f-18 is usual care or a partner of the new treatment

Codes

What other systems call florbetaben f-18 · ClinicalTrials.gg INT005250

  • MeSH (NLM) C5277564-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) TLA7312TOIFLORBETABEN F-18Confirmed FDA, NLM, Wikidata
  • RxNorm 1492940Confirmed FDA, Wikidata
  • Wikidata Q17014149florbetaben f-18Confirmed FDA, NLM, Wikidata
  • DrugBank DB09148One source Wikidata

Also registered as florbetaben (UNII BMO5G62HGB).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.